Ingrid Abrahamsen, Vice President, Clinical Operations at Relay Therapeutics, shared a post on LinkedIn:
“I’m excited to share that I’ve taken on a new role as Vice President, Clinical Operations at Relay Therapeutics leading the zovegalisib program in breast cancer.
There’s meaningful work ahead to move this therapy closer to patients, and I’m grateful for the journey that got me here and am energized for what’s ahead!”
Other articles on OncoDaily.